Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Proteomics infographic

4 Mar 2019
General interest

As part of our mini-Spotlight on proteomics, we carried out a survey to gain an insight into the trends, challenges and developments associated with proteomics R&D. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

Proteomics infographic web-01

Top content

  • AI-powered liquid biopsy could uncover early signs of liver disease
  • What to look out for at Analytica 2026
  • US FDA takes further steps to streamline biosimilar development

Related tags

infographic proteomics Spotlight Survey
Previous article Next article

Related articles

4 MAR 2019 GENERAL INTEREST
Spotlight survey on cellular and gene therapy
10 MAR 2017 NEWS
Cancer subtypes could be distinguished using metabolomic analysis
LC–MS for bioanalytical discovery
30 SEP 2020 GENERAL INTEREST
LC–MS in early discovery-stage workflows
8 JUL 2015 COLLABORATIONS AND MERGERS
Press release: Thermo Fisher Scientific proteomics facility for disease target discovery opens at Gladstone Institutes
30 APR 2010 CLINICAL
Cancer-related forecast biomarkers: a topic in focus of the Worldwide Innovative Network in Personalized Cancer Medicine (WIN)
3 JUL 2014 COLLABORATIONS AND MERGERS
New collaboration involving Skyline quantitative proteomics software and LC–MS/MS platforms
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone